advertisement
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (154)
Showing records 1 to 25
Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation91466 Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model
Rodrigo MJ
Biomaterials science 2020; 8: 6246-6260
90873 Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)
Medeiros FA
Ophthalmology 2020; 127: 1627-1641
91695 Effects of Benzalkonium Chloride in Ophthalmic Eyedrop Medications on Corneal Epithelium
Seino S
Yakugaku Zasshi 2021; 141: 35-39
91260 Assessment of Ocular Surface Disease in Glaucoma Patients in Ghana
Kobia-Acquah E
Journal of Glaucoma 2021; 30: 180-186
91141 A Tenon's capsule/bulbar conjunctiva interface biomimetic to model fibrosis and local drug delivery
Kozdon K
PLoS ONE 2020; 15: e0241569
91553 Novel Drug Delivery Systems Fighting Glaucoma: Formulation Obstacles and Solutions
Rahić O
Pharmaceutics 2020; 13:
91202 Effect of Autologous Serum Eyedrops on Ocular Surface Disease Caused by Preserved Glaucoma Eyedrops
So HR
Journal of clinical medicine 2020; 9:
91624 Signs and Symptoms of Ocular Surface Disease: The Reasons for Patient Dissatisfaction with Glaucoma Treatments
Stalmans I
Clinical Ophthalmology 2020; 14: 3675-3680
91669 Topical Bimatoprost Insert for Primary Open-Angle Glaucoma and Ocular Hypertension Treatment - A Phase II Controlled Study
Rubião F
Current Drug Delivery 2020; 0:
91648 Assessment of ocular surface disease in glaucoma patients with benzalkonium chloride-preserved latanoprost eye drops: a short-term longitudinal study
Su CC
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 1243-1251
91799 Novel Eye Drop Delivery Aid Improves Outcomes and Satisfaction
Sanchez FG
Ophthalmology. Glaucoma 2021; 0:
91846 Angiotensin Receptor Blockers in cyclodextrin nanoparticle eye drops: Ocular pharmacokinetics and pharmacologic effect on intraocular pressure
Lorenzo-Soler L
Acta Ophthalmologica 2021; 99: 376-382
91342 THE EFFECT OF THERAPY ON THE OCULAR SURFACE IN PATIENTS WITH UNILATERAL PEDIATRIC GLAUCOMA Purpose: The aim of the study was to evaluate ocular surface and
Janderová M
Česka a Slovenska Oftalmologie 2021; 77: 28-34
91819 Topical preservative-free ophthalmic treatments: an unmet clinical need
Figus M
Expert Opinion on Drug Delivery 2020; 0: 1-18
91447 Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients
Ruangvaravate N
Clinical Ophthalmology 2020; 14: 3109-3119
91252 Soft Contact Lens with Embedded Microtubes for Sustained and Self-Adaptive Drug Delivery for Glaucoma Treatment
Ding X
ACS applied materials & interfaces 2020; 12: 45789-45795
91466 Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model
Rodrigo MJ
Biomaterials science 2020; 8: 6246-6260
91324 Effect of preservative-free and preserved prostaglandin analogues on the histology of cornea of adult male Guinea pigs following repeated exposure
Ali AF
Folia morphologica 2022; 81: 52-64
91725 Physiochemical Properties and Cytotoxicity of a Benzalkonium Chloride-Free, Micellar Emulsion Ophthalmic Formulation of Latanoprost
Halder A
Clinical Ophthalmology 2020; 14: 3057-3064
90987 Understanding the Dual Dilemma of Dry Eye and Glaucoma: An International Review
Nijm LM
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2020; 9: 481-490
91799 Novel Eye Drop Delivery Aid Improves Outcomes and Satisfaction
Sanchez FG
Ophthalmology. Glaucoma 2021; 0:
91266 Assessment of Corneal Epithelium Thickness in Glaucomatous Patients Undergoing Medical Treatment
Halkiadakis I
Journal of Glaucoma 2021; 30: 44-49
91577 Patients' Experience of Using Eye Drop Guide Device to Aid Self-Administration of Glaucoma Medications
Sakiyalak D
Clinical Ophthalmology 2020; 14: 3781-3788
90921 Glaucoma: Management and Future Perspectives for Nanotechnology-Based Treatment Modalities
El Hoffy NM
European Journal of Pharmaceutical Sciences 2021; 158: 105648
91413 Sustained-release drug delivery systems for the treatment of glaucoma
Kesav NP
International Journal of Ophthalmology 2021; 14: 148-159